Knafo Klimor Architects
www.kkarc.com

T + 972.4.8243147 I office@kkarc.com I 2 Hasvyonim st. I Haifa 3464119, Israel
T + 972.3.5624262 I tlv@kkarc.com I 14 Karlibach st. I Tel-Aviv 64730, Israel

Knafo Klimor Architects was founded in 1980 by Tagit Klimor and David Knafo. Employing a holistic approach to architecture, the firm's objective is to embrace wider environmental and social concerns while striving for excellence in design and original architectural expressions. The firm has established a reputation of providing an innovative approach to design solutions and an uncompromising attitude to design quality.

The firm is based on its commitment to build a lasting relationship with its clients. With a diverse staff of architects, urbanists and designers, Knafo Klimor Architects has been responsible for designing a wide variety of large-scale projects in the highest architectural standard. Among the firm's clients are government offices and local authorities, private developers and construction companies.
Comprehensive approach, involvement throughout all phases of the design and construction process has consistently resulted in award-winning prizes for the firm's professional achievements. The firm's projects have been featured in professional journals worldwide, and have been exhibited in numerous galleries and architectural institutions.

Knafo Klimor Architects is dedicated to a thoughtful, original and contemporary architecture that aims to inspire and to promote a healthy sustainable lifestyle. As part of its dedication for environmental issues and its belief in the importance of education, both partners have been teaching for many years as senior lecturers at the Technion – Israel Institute of Technology, thus endowing their holistic approach to the young generation.

Knafo Klimor Architects' work is derived from the belief that the effort to promote sustainability will lead to a real change and will bring back the human dimension in design towards a more sustainable environment and a balanced society.

Project Team: Tagit Klimor, David Knafo, Or Regev, Uri Hallel, Arie Hayun & Heba Saleh

Prof. Ronit Satchi-Fainaro, Ph.D.
The Laboratory of Ronit Satchi-Fainaro

Head, Cancer Angiogenesis and Nanomedicine Laboratory
Chair, Department of Physiology and Pharmacology, President, Israeli Chapter of The Controlled Release Society

Sackler Faculty of Medicine, Room 607Tel Aviv University, Tel Aviv 69978
IsraelTel: +972-3-640 7427 (Office); Tel: +972-3-640 8733 (Lab)Fax: +972-3-640 9108;
Email: ronitsf@post.tau.ac.il

Prof. Ronit Satchi-Fainaro (Ph.D.) is Head of the Cancer Angiogenesis & Nanomedicine Laboratory; Chair of the Department of Physiology & Pharmacology, Sackler Faculty of Medicine and serves on the Preclinical Dekanat of the Faculty of Medicine. Prof. Satchi-Fainaro received her Bachelor of Pharmacy from the Hebrew University, Israel (1995) and her Ph.D. from the University of London, UK (1999). She then spent two years as postdoctoral fellow at Harvard University and Children’s Hospital Boston working with Judah Folkman on novel angiogenesis-targeted nanomedicines. In 2003, she was appointed Instructor in Surgery at Boston Children’s Hospital and Harvard Medical School and continues to have a Visiting Associate Professor position there to date. She joined Tel Aviv University in 2006.

Prof. Satchi-Fainaro is a leader in the field of nanomedicine and angiogenesis (cancer and vascular biology). She has major expertise in tumor biology, tumor dormancy, angiogenesis, molecular imaging, non-invasive intravital imaging of animal models, personalized nanomedicines for cancer theranostics (therapy and diagnostics). Throughout, she has maintained an interest in understanding the biological rationale for the design of nanomedicines suitable for transfer into clinical testing. Her multi-disciplinary research laboratory focuses on basic research elucidating the mechanisms underlying the switch from dormancy leading to the discovery of new molecular targets interrupting host-tumor interactions. Her approach is followed by the design of highly-selective targeting molecules integrating biology, chemistry, protein engineering, molecular imaging, computational approaches, material sciences and nanotechnology to selectively guide drugs into pathological sites.

Prof. Satchi-Fainaro serves as advisor to several Israeli and International Biotechnology and Pharmaceutical companies, is President of the Israeli Society for Controlled Release, and is on the editorial boards of several biological and chemical journals. She has published more than 70 papers, 12 book chapters, edited 2 books, is named inventor on 40 patents, and was awarded numerous prestigious grants and prizes, among them Fulbright, Rothschild, ERC Consolidator Award, Alon, Young Investigator Award of the EACR, Juludan Prize and Teva Pharmaceutical Industries Founders Award. Her scientific achievements were acknowledged numerous times by inclusion in honorary lists by leading magazines such as Forbes, The Marker, Globes and Calcalist.

Eng. Yacov Biofcic
ER&D - Engineering, Research & Development

Mechanical & Electrical implementation


Acknowledgements

We thank Prof. Joseph Klafter and Tel Aviv University for their kind and generous support.
Thank you to 'Palram Industries Ltd’ for their significant contribution and cooperation.